Several lines of evidence have indicated that CCNB1 is useful as a diagnostic or prognostic biomarker in rhabdomyosarcoma, hepatocellular carcinoma, and meningioma (42, 45, 46). The gene discussed is CCNB1; the disease is meningioma.